It is our pleasure to invite you to participate in the The International Annual Congress on Controversies on Cannabis-Based Medicines (Med-Cannabis2018) which will take place 25-26 June 2018 in Vienna, Austria.
A strong public and patient demand has led to the decision to allow cannabis products for medical use in most European countries. There is a lot of basic-science and clinical research on the potential use of cannabis products for chronic pain and cancer management as well as controversies on the potential harms.
This Congress will bring together researchers, clinicians, trialists, methodologists, industry professionals, the European Monitoring Centre for Drugs and Drug Addiction, the European Medical Agency and national cannabis agencies to update the current state of knowledge and of controversies and to outline some visions of the potential of cannabis based medicines.
The program will include a wealth of knowledge from our world renowned panel of experts. We look forward to seeing you in June 2018 in the charming city of Vienna.